Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia. (Q50214509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Omar Perbellini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Michele Gottardi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Michael Steurer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Clemens Feistritzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Ciaran Murphy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Elva Eakins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Muriel Van Schilfgaarde

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Daisy Corvetta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Angela Maria Di Pierro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Irene Pusceddu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Luigi Marcheselli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Roberto Gambato

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Martin Langes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Dino Veneri

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Enrica Pacquola

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Filippo Gherlinzoni

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Andrea Mega

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Martina Tauber

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Guido Mazzoleni

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Elisa Piva

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Mario Plebani

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Mauro Krampera

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Günther Gastl

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

14 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

21-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

How I treat the acquired von Willebrand syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

How to manage essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Measuring circulating cell-derived microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Endothelial microparticles and endothelial damage: 'the tip and the iceberg'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Circulating microparticles: pathophysiology and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Generalizability and transferability of meta-synthesis research findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Hydroxyurea, Leucopheresis, and Splenectomy in Chronic Myeloid Leukaemia at the Problastic Phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

The effects of anagrelide on human megakaryocytopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Adrenomedullin in liver transplantation and its relationship with vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

E-selectin supports neutrophil rolling in vitro under conditions of flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Endoglin: a critical mediator of cardiovascular health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Pre-analytical and analytical issues in the analysis of blood microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Overcoming limitations of microparticle measurement by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Flow cytometric measurement of microparticles: pitfalls and protocol modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Interference of chylomicrons in analysis of platelets by flow cytometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

Tetraspanin CD9 is required for microparticle release from coated-platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.02.001

10.1016/J.TRSL.2017.02.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259616%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference